GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2008 (Vol. 28, No. 7)

Origin of Life Prize

URL:www.us.net/life
  • Thorough approach
  • : A bit weak in some content areas
How much do you suppose it is worth to solve the issue of the origins of life to the satisfaction of the scientific community? $100,000? $500,000, $1,000,000? Well, the answer is the last number in the series and the anonymous nature of the prize money donation has, unfortunately, put a snag in the efforts to proceed with the contest, so you can’t enter it at this time, but the contest itself is worth noting and (I suspect) it will probably be opened up again soon. The purpose of the contest is to “stimulate research into chaos, complexity, information, probability, self-organization, and artificial life/intelligence theories as they relate directly to biochemical and molecular biological reality.” The four qualifications for winning the grand prize are too detailed to go into here, so I won’t, but from my perspective, they range from difficult to trivial to satisfy. Point number four, for example, seems to have been made by someone who has no knowledge of how enzymes work. Is the contest for you? There’s only one way to determine that – check it out.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?